Charles Zhou

Stock Analyst at UBS

(0.69)
# 3,570
Out of 4,874 analysts
10
Total ratings
42.86%
Success rate
-11%
Average return

Stocks Rated by Charles Zhou

Futu Holdings
Mar 17, 2025
Maintains: Buy
Price Target: $130$136
Current: $123.21
Upside: +10.38%
Zymeworks
Mar 8, 2023
Reiterates: Buy
Price Target: $16
Current: $12.37
Upside: +29.35%
Cogent Biosciences
Jun 28, 2022
Initiates: Buy
Price Target: $15
Current: $7.34
Upside: +104.50%
MacroGenics
May 5, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.27
Upside: -
PMV Pharmaceuticals
Aug 2, 2021
Initiates: Buy
Price Target: $56
Current: $1.09
Upside: +5,061.29%
Repare Therapeutics
Jun 28, 2021
Initiates: Buy
Price Target: $46
Current: $1.40
Upside: +3,185.71%
Qudian
Jan 22, 2020
Downgrades: Neutral
Price Target: n/a
Current: $2.85
Upside: -